galantamine and Psychoses

galantamine has been researched along with Psychoses in 10 studies

Research

Studies (10)

TimeframeStudies, this research(%)All Research%
pre-19901 (10.00)18.7374
1990's0 (0.00)18.2507
2000's3 (30.00)29.6817
2010's6 (60.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Adams, HC; Blais, MA; Dubois, CM; Durham, LE; Fava, M; Matthews, JD; Park, LT; Rooney, KO; Seabrook, RC; Siefert, CJ; van Nieuwenhuizen, AO; Welch, CA1
Brown, CH; Deutsch, SI; Rosse, RB; Rosse, SM; Schooler, NR; Schwartz, BL1
Correll, CU; Lu, RB; Luchini, C; Solmi, M; Stubbs, B; Veronese, N; Zaninotto, L1
Adams, HA; Blanchard, JJ; Buchanan, RW; Carpenter, WT; Cohen, AS; Gold, J; Kelly, DL; McMahon, RP; Mitchell, KR; Strauss, GP1
Boggs, DL; Buchanan, RW; Conley, RR; Dickinson, D; Kelly, DL; McMahon, RP; Weiner, E1
Osborn, GG; Saunders, AV1
Jayaram, MB; Kour, K; Singh, J1
BOIADZHIEVA, M; SHCHEREVA, T; TEMKOV, I1
Bennouna, M; Defranoux, L; Greene, VB1
Hicks, PB; Schubert, MH; Young, KA1

Reviews

3 review(s) available for galantamine and Psychoses

ArticleYear
Acetylcholinesterase inhibitors and memantine in bipolar disorder: A systematic review and best evidence synthesis of the efficacy and safety for multiple disease dimensions.
    Journal of affective disorders, 2016, Volume: 197

    Topics: Adult; Bipolar Disorder; Case-Control Studies; Cholinesterase Inhibitors; Clinical Trials as Topic; Depression; Depressive Disorder; Donepezil; Evidence-Based Medicine; Excitatory Amino Acid Antagonists; Female; Galantamine; Humans; Indans; Male; Memantine; Middle Aged; Piperidines; Psychotic Disorders; Randomized Controlled Trials as Topic; Treatment Outcome

2016
Current treatments for patients with Alzheimer disease.
    The Journal of the American Osteopathic Association, 2010, Volume: 110, Issue:9 Suppl 8

    Topics: Aggression; Alzheimer Disease; Behavior Therapy; Cholinesterase Inhibitors; Depression; Excitatory Amino Acid Antagonists; Galantamine; Health Status; Humans; Memantine; Neuroprotective Agents; Parasympathomimetics; Phenylcarbamates; Psychomotor Agitation; Psychotherapy; Psychotic Disorders; Rivastigmine; Time Factors; United States; United States Food and Drug Administration

2010
Acetylcholinesterase inhibitors for schizophrenia.
    The Cochrane database of systematic reviews, 2012, Jan-18, Volume: 1

    Topics: Antipsychotic Agents; Cholinesterase Inhibitors; Donepezil; Galantamine; Humans; Indans; Phenylcarbamates; Piperidines; Psychotic Disorders; Randomized Controlled Trials as Topic; Rivastigmine; Schizophrenia; Schizophrenic Psychology

2012

Trials

5 trial(s) available for galantamine and Psychoses

ArticleYear
A double-blind, placebo-controlled study of the impact of galantamine on anterograde memory impairment during electroconvulsive therapy.
    The journal of ECT, 2013, Volume: 29, Issue:3

    Topics: Affect; Amnesia, Anterograde; Cognition; Cohort Studies; Depressive Disorder, Major; Double-Blind Method; Electroconvulsive Therapy; Female; Galantamine; Humans; Inpatients; Male; Middle Aged; Neuropsychological Tests; Nootropic Agents; Psychiatric Status Rating Scales; Psychotic Disorders

2013
Targeting alpha-7 nicotinic neurotransmission in schizophrenia: a novel agonist strategy.
    Schizophrenia research, 2013, Volume: 148, Issue:1-3

    Topics: Adult; Aged; alpha7 Nicotinic Acetylcholine Receptor; Cognition Disorders; Cytidine Diphosphate Choline; Double-Blind Method; Female; Galantamine; Humans; Male; Middle Aged; Neuropsychological Tests; Nootropic Agents; Psychiatric Status Rating Scales; Psychotic Disorders; Schizophrenia; Synaptic Transmission; Treatment Outcome

2013
The effects of oxytocin and galantamine on objectively-defined vocal and facial expression: Data from the CIDAR study.
    Schizophrenia research, 2017, Volume: 188

    Topics: Adult; Antipsychotic Agents; Facial Expression; Galantamine; Humans; Interpersonal Relations; Interview, Psychological; Middle Aged; Neuropsychological Tests; Oxytocin; Psychotic Disorders; Schizophrenia; Schizophrenic Psychology; Social Behavior; Speech Production Measurement; Treatment Outcome; Video Recording; Voice; Young Adult

2017
Lack of beneficial galantamine effect for smoking behavior: a double-blind randomized trial in people with schizophrenia.
    Schizophrenia research, 2008, Volume: 103, Issue:1-3

    Topics: Adult; alpha7 Nicotinic Acetylcholine Receptor; Antipsychotic Agents; Breath Tests; Carbon Monoxide; Double-Blind Method; Drug Therapy, Combination; Female; Galantamine; Humans; Male; Middle Aged; Nootropic Agents; Psychiatric Status Rating Scales; Psychotic Disorders; Receptors, Nicotinic; Schizophrenia; Schizophrenic Psychology; Self Medication; Smoking Cessation

2008
Galantamine improves cognition in schizophrenic patients stabilized on risperidone.
    Biological psychiatry, 2006, Sep-15, Volume: 60, Issue:6

    Topics: Adult; Antipsychotic Agents; Cholinesterase Inhibitors; Cognition; Double-Blind Method; Female; Galantamine; Humans; Male; Middle Aged; Neuropsychological Tests; Psychotic Disorders; Risperidone; Schizophrenia

2006

Other Studies

2 other study(ies) available for galantamine and Psychoses

ArticleYear
[Changes in the cholinesterase activity of the blood serum in some psychoses under the influence of nivaline].
    Nauchni trudove na Visshiia meditsinski institut, Sofiia, 1960, Volume: 39(6)

    Topics: Alkaloids; Cholinesterases; Electroconvulsive Therapy; Galantamine; Parasympathomimetics; Psychotherapy; Psychotic Disorders; Serum

1960
Adjuvant galantamine to risperidone improves negative and cognitive symptoms in a patient presenting with schizophrenialike psychosis after traumatic brain injury.
    Journal of clinical psychopharmacology, 2005, Volume: 25, Issue:5

    Topics: Adult; Antipsychotic Agents; Brain Hemorrhage, Traumatic; Cholinesterase Inhibitors; Cognition Disorders; Female; Galantamine; Humans; Psychiatric Status Rating Scales; Psychotic Disorders; Risperidone; Schizophrenic Psychology

2005